Results 21 to 30 of about 2,546,082 (211)
The Scientific World Journal, Volume 2012, Issue 1, 2012., 2012 Four new 1,2,3‐triazole phthalimide derivatives with a potent anti‐inflammatory activity have been synthesized in the good yields by the 1,3‐dipolar cycloaddition reaction from N‐(azido‐alkyl)phthalimides and terminal alkynes. The anti‐inflammatory activity was determined by injecting carrageenan through the plantar tissue of the right hind paw of ...
Shalom Pôrto de Oliveira Assis +7 more
wiley +1 more source
Lipoprotein(a) Removal Still a Mystery
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 See Article by Shapiro et ...
Paul Nestel
doaj +1 more source
Shapes and Positions of Black Hole Shadows in Accretion Disks and Spin Parameters of Black Holes [PDF]
J.Korean Phys.Soc.45:S1808-S1812,2004;
Astrophys.J.611:996-1004,2004, 2004 Can we determine a spin parameter of a black hole by observation of a black hole shadow in an accretion disk? In order to answer this question, we make a qualitative analysis and a quantitative analysis of a shape and a position of a black hole shadow casted by a rotating black hole on an optically thick accretion disk and its dependence on an angular ...
arxiv +1 more source
Elevated Lipoprotein(a) Linked to Recurrent Cardiovascular Events – A Case Report
Journal of Interdisciplinary Medicine, 2022 The role of lipoprotein(a) [Lp(a)] in the development of atherosclerosis has been recently recognized, and the current recommendation is to measure Lp(a) once in a lifetime in all individuals, in order to identify those at risk for developing an acute ...
Roșca Aurelian +2 more
doaj +1 more source
Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease
Open Heart, 2022 Objective Lipoprotein(a) (Lp(a)) is an important genetically determined risk factor for atherosclerotic vascular disease (ASCVD). With the development of Lp(a)-lowering therapies, this study sought to characterise patterns of Lp(a) levels in a global ...
Ulf Landmesser +23 more
doaj +1 more source
Lipids in Health and Disease, 2011 Background Oxidized lipoprotein(a) (oxLp(a)) can be a more potent marker of atherogenesis than native Lp(a), although Lp(a) is considered to be a risk factor for atherosclerotic diseases.
Taniguchi Nobuyuki +4 more
doaj +1 more source
Relationship between lipoprotein(a) and colorectal cancer among inpatients: a retrospective study
Frontiers in Oncology, 2023 The present study was to explore the association between lipoprotein(a) [Lp(a)] and colorectal cancer (CRC) among inpatients. This study included 2822 participants (393 cases vs. 2429 controls) between April 2015 and June 2022. Logistic regression models,
Huijie Wang +7 more
doaj +1 more source
Association between serum lipoprotein(a) and mildly reduced eGFR: a cross-sectional study
BMC Nephrology, 2023 Lipoprotein(a) [Lp(a)] is a risk factor for cardiovascular disease (CVD) and aortic stenosis. However, the data on the relationship between Lp(a) and mildly reduced estimated glomerular filtration rate (eGFR) has been disputed.
Hong Zhang +8 more
doaj +1 more source
The BM@N spectrometer at the NICA accelerator complex [PDF]
arXiv, 2023 BM@N (Baryonic Matter at Nuclotron) is the first experiment operating and taking data at the Nuclotron/NICA ion-accelerating complex.The aim of the BM@N experiment is to study interactions of relativistic heavy-ion beams with fixed targets. We present a technical description of the BM@N spectrometer including all its subsystems.
arxiv
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Background Elevated lipoprotein(a) (Lp(a)), a low‐density lipoprotein‐like particle bound to the polymorphic apolipoprotein(a) (apo(a)), may be causal for cardiovascular disease. However, the metabolism of Lp(a) in humans is poorly understood.
Dick C. Chan +5 more
doaj +1 more source